The 2025 U.S. Bioscience Industry: A Powerful Engine for State Economies
The Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released its latest biennial report on best practices in bioscience economic development initiatives. The report outlines the policy strategies - R&D incentives, biomanufacturing investments, workforce development programs, and early-stage capital tools - driving U.S. biotechnology leadership.
The new BIO & CSBA Best Practices report is out. Discover key policy strategies—from R&D incentives to workforce programs—driving US biotech leadership and economic development.
New report “The U.S. Bioscience Industry: A Powerful Engine for State Economies” highlights the critical policy initiatives that are helping states strengthen the nation’s biotech future.
BIO and CSBA released its latest biennial report on best practices in bioscience economic development initiatives. The report outlines key policy strategies driving U.S. biotechnology leadership.